Literature DB >> 2044557

Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation.

G Cecchetti1, A Binda, A Piperno, F Nador, S Fargion, G Fiorelli.   

Abstract

Thirty-six consecutive patients with idiopathic haemochromatosis (IH) were studied by electrocardiography (ECG), polygraphy, M-mode and 2-D echocardiography and Doppler-echocardiography. No significant correlations were found between ECG, PEP/LVET ratio and echocardiographic measurements. Left ventricular (LV) enlargement with impaired LV systolic function was present only in three patients (5.5%), of whom two died during iron-depleting therapy because of cardiovascular complications. Compared with controls, echocardiographic abnormalities were significantly more frequent and marked in subjects with higher iron overload than in those in whom it was lower. Ten patients were studied before and after iron depletion, nine of whom had only mild echocardiographic abnormalities at baseline examination. Significant reduction of end-diastolic thickness of the interventricular septum and LV mass (P less than 0.01 and less than 0.02 respectively) was observed. Also the end-diastolic thickness of the LV posterior wall and the end-systolic diameter of the left atrium reduced although not to a significant degree. The increased thickness of ventricular walls without impairment of LV systolic function is probably the first and still reversible cardiac alteration due to iron deposition in the myocardium. Later, with increasing iron overload, LV function becomes impaired and dilated cardiomyopathy develops. Early diagnosis and treatment of IH cardiopathy is needed before irreversible cardiac damage occurs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044557     DOI: 10.1093/oxfordjournals.eurheartj.a059873

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.

Authors:  P D Jensen; F T Jensen; T Christensen; L Heickendorff; L G Jensen; J Ellegaard
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

2.  Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction.

Authors:  A Piperno; M R Rivolta; R D'Alba; S Fargion; F Rovelli; A Ghezzi; M Micheli; G Fiorelli
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

3.  Improved R2* measurements in myocardial iron overload.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

4.  A patient with a rare cause of elevated troponin I.

Authors:  Antonios Kilias; Karin Klingel; Meinrad Gawaz; Ulrich Kramer; Peter Seizer
Journal:  Clin Res Cardiol       Date:  2015-04-28       Impact factor: 5.460

Review 5.  Therapeutic Strategies Targeting Inherited Cardiomyopathies.

Authors:  Kenneth Varian; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 6.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

Review 7.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

8.  Atrial and ventricular function in thalassemic patients with supra-ventricular arrhythmias.

Authors:  Ines Monte; Davide Capodanno; Elisa Nicolosi; Salvatore Licciardi; Enrica Talini; Vitantonio Di Bello
Journal:  Heart Int       Date:  2009-06-30

Review 9.  The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body.

Authors:  Christal A Worthen; Caroline A Enns
Journal:  Front Pharmacol       Date:  2014-03-06       Impact factor: 5.810

10.  Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis.

Authors:  Abitha Sukumaran; JuOae Chang; Murui Han; Shrutika Mintri; Ban-An Khaw; Jonghan Kim
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.